Intelligent Bio Solutions Stock Debt To Equity

INBS Stock

USD 1.55 0.01 0.64%

Fundamental analysis of Intelligent Bio allows traders to better anticipate movements in Intelligent Bio's stock price by examining its financial health and performance throughout various phases of its business cycle.

		Last Reported	Projected for Next Year
	Debt To Equity	0.09	0.10

Debt To Equity is likely to gain to 0.1 in 2025.

Build AI portfolio with Intelligent Stock

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Intelligent Bio Solutions Company Debt To Equity Analysis

Intelligent Bio's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.

Current Intelligent Bio Debt To Equity

0.0989

Most of Intelligent Bio's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Intelligent Bio Solutions is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Intelligent Debt To Equity Driver Correlations

Understanding the fundamental principles of building solid financial models for Intelligent Bio is extremely important. It helps to project a fair market value of Intelligent Stock properly, considering its historical fundamentals such as Debt To Equity. Since Intelligent Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Intelligent Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Intelligent Bio's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Receivables	Net Tangible Assets	Net Invested Capital	Short Long Term Debt	Capital Stock	Net Working Capital	Current Deferred Revenue	Deferred Long Term Liab	Property Plant Equipment	Long Term Debt	Short Term Investments	Intangible Assets
Total Assets		0.97	-0.94	-0.83	0.78	-0.41	0.96	-0.87	-0.15	0.9	0.93	0.96	-0.93	-0.92	0.92	0.65	-0.32	0.6	-0.32	-0.32	-0.5
Total Stockholder Equity	0.97		-0.95	-0.87	0.75	-0.52	0.93	-0.9	-0.2	0.87	0.91	0.99	-0.96	-0.96	0.9	0.72	-0.5	0.63	-0.5	-0.5	-0.63
Net Debt	-0.94	-0.95		0.72	-0.7	0.4	-0.97	0.9	0.28	-0.96	-0.92	-0.94	0.9	0.9	-0.98	-0.64	0.33	-0.41	0.33	0.33	0.45
Retained Earnings	-0.83	-0.87	0.72		-0.64	0.56	-0.71	0.77	0.03	-0.59	-0.77	-0.88	0.92	0.91	-0.6	-0.81	0.52	-0.85	0.52	0.52	0.73
Accounts Payable	0.78	0.75	-0.7	-0.64		-0.03	0.73	-0.68	0.1	0.75	0.79	0.75	-0.75	-0.73	0.71	0.32	-0.18	0.41	-0.18	-0.18	-0.18
Total Liab	-0.41	-0.52	0.4	0.56	-0.03		-0.36	0.44	0.45	-0.25	-0.19	-0.53	0.51	0.56	-0.31	-0.74	0.66	-0.55	0.66	0.66	0.77
Total Current Assets	0.96	0.93	-0.97	-0.71	0.73	-0.36		-0.8	-0.1	0.96	0.93	0.9	-0.85	-0.84	0.98	0.59	-0.27	0.38	-0.27	-0.27	-0.41
Short Term Debt	-0.87	-0.9	0.9	0.77	-0.68	0.44	-0.8		0.49	-0.82	-0.81	-0.94	0.94	0.95	-0.82	-0.7	0.4	-0.62	0.4	0.4	0.51
Common Stock	-0.15	-0.2	0.28	0.03	0.1	0.45	-0.1	0.49		-0.18	0.02	-0.29	0.25	0.32	-0.23	-0.2	0.13	-0.21	0.13	0.13	0.17
Net Receivables	0.9	0.87	-0.96	-0.59	0.75	-0.25	0.96	-0.82	-0.18		0.92	0.86	-0.82	-0.81	0.97	0.53	-0.2	0.23	-0.2	-0.2	-0.24
Net Tangible Assets	0.93	0.91	-0.92	-0.77	0.79	-0.19	0.93	-0.81	0.02	0.92		0.89	-0.89	-0.86	0.89	0.6	-0.27	0.43	-0.27	-0.27	-0.36
Net Invested Capital	0.96	0.99	-0.94	-0.88	0.75	-0.53	0.9	-0.94	-0.29	0.86	0.89		-0.98	-0.98	0.88	0.75	-0.49	0.67	-0.49	-0.49	-0.62
Short Long Term Debt	-0.93	-0.96	0.9	0.92	-0.75	0.51	-0.85	0.94	0.25	-0.82	-0.89	-0.98		1.0	-0.81	-0.79	0.45	-0.71	0.45	0.45	0.59
Capital Stock	-0.92	-0.96	0.9	0.91	-0.73	0.56	-0.84	0.95	0.32	-0.81	-0.86	-0.98	1.0		-0.8	-0.79	0.46	-0.72	0.46	0.46	0.6
Net Working Capital	0.92	0.9	-0.98	-0.6	0.71	-0.31	0.98	-0.82	-0.23	0.97	0.89	0.88	-0.81	-0.8		0.5	-0.24	0.28	-0.24	-0.24	-0.34
Current Deferred Revenue	0.65	0.72	-0.64	-0.81	0.32	-0.74	0.59	-0.7	-0.2	0.53	0.6	0.75	-0.79	-0.79	0.5		-0.62	0.67	-0.62	-0.62	-0.74
Deferred Long Term Liab	-0.32	-0.5	0.33	0.52	-0.18	0.66	-0.27	0.4	0.13	-0.2	-0.27	-0.49	0.45	0.46	-0.24	-0.62		-0.47	1.0	1.0	0.87
Property Plant Equipment	0.6	0.63	-0.41	-0.85	0.41	-0.55	0.38	-0.62	-0.21	0.23	0.43	0.67	-0.71	-0.72	0.28	0.67	-0.47		-0.47	-0.47	-0.74
Long Term Debt	-0.32	-0.5	0.33	0.52	-0.18	0.66	-0.27	0.4	0.13	-0.2	-0.27	-0.49	0.45	0.46	-0.24	-0.62	1.0	-0.47		1.0	0.87
Short Term Investments	-0.32	-0.5	0.33	0.52	-0.18	0.66	-0.27	0.4	0.13	-0.2	-0.27	-0.49	0.45	0.46	-0.24	-0.62	1.0	-0.47	1.0		0.87
Intangible Assets	-0.5	-0.63	0.45	0.73	-0.18	0.77	-0.41	0.51	0.17	-0.24	-0.36	-0.62	0.59	0.6	-0.34	-0.74	0.87	-0.74	0.87	0.87

Click cells to compare fundamentals

High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.

Competition

Predict Intelligent Bio

Debt To Equity Over Time

Intelligent Total Stockholder Equity

Total Stockholder Equity

10.06 Million

At this time, Intelligent Bio's Total Stockholder Equity is comparatively stable compared to the past year.

Intelligent Debt To Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Intelligent Bio's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Intelligent Bio could also be used in its relative valuation, which is a method of valuing Intelligent Bio by comparing valuation metrics of similar companies.

Intelligent Bio is currently under evaluation in debt to equity category among its peers.

Intelligent Bio Current Valuation Drivers

We derive many important indicators used in calculating different scores of Intelligent Bio from analyzing Intelligent Bio's financial statements. These drivers represent accounts that assess Intelligent Bio's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Intelligent Bio's important valuation drivers and their relationship over time.

	2020	2021	2022	2023	2024	2025 (projected)
Market Cap	53.5M	9.7M	475.4K	787.9K	906.1K	860.8K
Enterprise Value	40.9M	1.5M	273.8K	(4.6M)	(5.3M)	(5.1M)

Intelligent Fundamentals

	Return On Equity	-1.29
	Return On Asset	-0.49
	Operating Margin	(3.50) %
	Current Valuation	9.3 M
	Shares Outstanding	7.43 M
	Shares Owned By Insiders	1.27 %
	Shares Owned By Institutions	11.95 %
	Number Of Shares Shorted	513.16 K
	Price To Book	2.27 X
	Price To Sales	3.95 X
	Revenue	3.11 M
	Gross Profit	1.73 M
	EBITDA	(8.81 M)
	Net Income	(10.19 M)
	Cash And Equivalents	8.28 M
	Cash Per Share	0.56 X
	Total Debt	871.44 K
	Current Ratio	2.33 X
	Book Value Per Share	0.75 X
	Cash Flow From Operations	(9.57 M)
	Short Ratio	2.79 X
	Earnings Per Share	(1.33) X
	Target Price	12.0
	Number Of Employees	50
	Beta	4.59
	Market Capitalization	11.6 M
	Total Asset	13.78 M
	Retained Earnings	(51.96 M)
	Working Capital	3.08 M
	Net Asset	13.78 M

About Intelligent Bio Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Intelligent Bio Solutions's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Intelligent Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Intelligent Bio Solutions based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Intelligent Stock Analysis

When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC